Skip to main content
OpenTrials
Completed

NCT Number: NCT07526233

The Effect of Maternal Scent and Knitted Octopus Application on Pain in Infants Diagnosed With Neonatal Asphyxia and Receiving Therapeutic Hypothermia Treatment

This study was designed to determine the effects of maternal scent and knitted octopus application on pain in infants born with asphyxia beyond 36 weeks' gestation and receiving Therapeutic Hypothermia (TH) treatment in the Neonatal Intensive Care Unit (NICU) of Gaziantep Private Anka Hospital. The study is a randomized controlled experimental study. Block randomization will be used as the randomization method.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Detailed Description

The neonatal period is characterized by increased sensitivity to environmental stimuli, including olfactory inputs. Early exposure to maternal odors may support physiological stability and behavioral regulation in newborns. In neonatal intensive care settings, maternal scent is commonly introduced using odor-bearing materials placed near the infant. In addition, supportive positioning tools such as soft objects may provide comfort and reduce stress-related responses.

This randomized controlled trial is designed to evaluate the effects of maternal scent exposure and the use of a knitted octopus on pain response in newborns undergoing therapeutic hypothermia for perinatal asphyxia. Participants will be randomly assigned to receive either maternal scent exposure, a knitted octopus intervention, or standard care.

Maternal scent exposure will be provided using maternal clothing and odor-absorbing materials placed near the infant to allow continuous exposure throughout the treatment period. The knitted octopus intervention involves placing a soft, hypoallergenic object in contact with the infant to provide tactile comfort.

Pain assessments will be performed at predefined intervals during the therapeutic hypothermia period using a validated neonatal pain scale. Data will be collected prospectively and analyzed to compare pain responses between groups.

The study aims to determine whether these non-pharmacological interventions can reduce pain and improve comfort in newborns receiving therapeutic hypothermia.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Babies with a gestational age of ≥36 and a postpartum age of ≤6 hours.
  • Babies diagnosed with asphyxia and receiving TH treatment in the NICU.
  • Babies not receiving respiratory support.
  • Newborns with family consent.

Exclusion criteria

  • Babies with congenital disorders,
  • Babies with syndromes/chromosomal disorders,
  • Babies who experience seizures while being warmed,
  • Babies whose parents wish to withdraw from the study during the study period,
  • Babies receiving analgesics

Treatment and study plan

scent

Other

We believe that exposure to the mother's scent and hugging the baby to a knitted octopus will reduce pain in the baby.

Other names: knitted octopus

Primary outcomes

  1. N-PASS Pain Score

    Time frame: From 6 hours after initiation of therapeutic hypothermia up to 72 hours (assessed every 3 hours)

    The Neonatal Pain, Agitation, and Sedation Scale (N-PASS) will be used to assess pain levels in newborns undergoing therapeutic hypothermia. The scale evaluates behavioral and physiological parameters, with higher scores indicating increased pain.

Sponsors and collaborators

Lead sponsor

Alev Sivasli

Other

Collaborators

  • Istanbul Nisantasi University

Registry information

Acronym: Pain in HIE

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 13, 2026
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.